Grigeo Klaipeda (Lithuania), which owns the major stake (more than 97.92%) in PJSC Mena Pack (Mena, Chernihiv region), a manufacturer of corrugated boxes, intends to use the right of squeeze-out.
According to a report by Mena Pack in the information disclosure system of the National Commission on Securities and Stock Market, it received the corresponding notification on November 27.
Grigeo Klaipeda has been holding the major stake in the company since 2012. The charter capital of the company is UAH 4.01 million, the nominal value of shares is UAH 5.
Mena Pack, which has been operating in the corrugated packaging market for more than 30 years, produces corrugated packaging made of three-layer corrugated cardboard for tobacco, food and construction industries.
Grigeo Klaipeda is part of Grigeo Group, the only manufacturer of chipboard, cardboard and sanitary paper in Lithuania and one of the largest in the Baltic States. Grigeo Klaipeda produces components for corrugated cardboard.
BUY, CORRUGATED BOXES, GRIGEO KLAIPEDA, MANUFACTURER, SHARES
The National Commission for the State Regulation of Energy, Housing and Utilities Services (NCER) has removed UAH 215.172 million from the tariff of national energy company Ukrenergo saved on procurement in 2017, which would entail the worsening of financial indicators of the state-run enterprise and its payments to the national budget. The press service of Ukrenergo reported that the commission at a meeting on Tuesday cut the company’s tariff for transmission for December 2018 to 3.45 kopecks per kilowatt.
The company said that only on September 4, 2018 the company was permitted to use UAH 215.17 million saved on procurement and obliged to provide a package of documents amending the investment program before October 1.
On September 21, Ukrenergo provided the commission with all the required information, including the approval of regional administrations and the Ministry of Energy and Coal during public hearings. At the same time, on October 24, it became known that the approvals provided by the company did not suit the commission, which demanded a separate letter of approval of changes from the relevant ministry.
As a result, the commission has withdrawn UAH 215.172 million from the tariff of Ukrenergo. The money at that time was already invested in projects for the construction and modernization of the energy infrastructure.
According to Ukrenergo CEO Vsevolod Kovalchuk, the withdrawal of this amount from the investment program is an unreasonable decision, as a result of which the financial indicators of the enterprise and its contributions to the national budget will decrease.
“In fact, this is a redistribution of funds between the energy market players. These funds should have been channeled to additional financing of transitional strategic facilities that are important for the entire industry. We are concerned that this decision will not lead to a decrease in wholesale electricity prices and will not affect the payments of end consumers, but it will negatively affect the indicators of gross income and profit of the company, its payments to the national budget,” Kovalchuhk said.
According to Ukrenergo, the total amount of the investment program of Ukrenergo for 2018 is UAH 2.61 billion. In the nine months ending September 2018, its actual implementation amounted to 94.2%. At the same time, funding continues for projects launched or pending in 2017.
Electronic register of sick notes created in Ukraine
KYIV. Nov 28 (Interfax-Ukraine) – The Cabinet of Ministers of Ukraine has created the electronic register of sick notes and disability certificates. “The government adopted a resolution of the Cabinet of Ministers of Ukraine on the creation of an electronic register of sick notes, which provides for the creation of an electronic register of sick notes and disability certificates as a system for accumulating, storing and using information on issued, extended and recorded sick notes and disability certificates, using the information infrastructure of the register of insured persons of the public register of compulsory public social insurance,” the press service of the Social Policy Ministry said in a statement. The government also defined the tasks of the central executive authorities jointly with the Social Insurance Fund of Ukraine to develop a draft provisions on the electronic register of sick notes and disability certificates by February 1, 2019, submit it to the Cabinet of Ministers and provide the technical capabilities required for the operation of the register.
The Ukrainian World Congress (UWC) has appointed Paul Grod to head the organization. “I would be glad to cooperate with Paul as new UWC president. I also thank Eugene Czolij, the previous president, for the years of dedicated work in the interests of the development of our state,” Ukrainian Prime Minister Volodymyr Groysman said on Facebook.
According to the government’s press service, the prime minister met with Grod and congratulated him on his appointment. Groysman said Ukraine feels the support of the UWC. “Your role is important. We feel today the partnership of the UWC. And I am glad that we have an understanding and readiness to resolve any issues,” said the Prime Minister.
Since its establishment in 1967, the Ukrainian World Congress (UWC) (until 1993 – the World Congress of Free Ukrainians) meets every five years to review its activities and to set the priorities for the future, including the election of the president and leadership of the UWC.
The Indian pharmaceutical market in Ukraine could grow by 2% in 2019, President of the Indian Pharmaceutical Manufacturers’ Association (IPMA) Dr. Menon has said at a press conference at Interfax-Ukraine. “Indian pharmaceutical products consistently rank third among importing countries in Ukraine. We are optimistic about 2019 and we expect the market of Indian pharmaceutical products to grow in Ukraine,” he said.
Indian Ambassador to Ukraine Partha Satpathy, in turn, notes that India can meet the needs of Ukraine in inexpensive and high-quality medicines.
“Indian pharmaceutical products account for only 5% of the total pharmaceutical consumption in Ukraine. This is a large amount – more than $150 million, but in today’s conditions Ukraine needs effective medicines that will not be very expensive. This is where Indian pharmaceutical manufacturers will help, whose medicines cost one-sixth, one-tenth of the western analogues. All medicines are certified by the WHO,” he said.
The ambassador also noted that India ranks first in terms of the number of GMP certified products, therefore the Indian pharmaceutical market in Ukraine should grow.
